Evidence map›Paper›PMID 24722988›Full record

ArticleThe Journal of biological chemistry2014

Identification of 5' AMP-activated kinase as a target of reactive aldehydes during chronic ingestion of high concentrations of ethanol.

Colin T Shearn, Donald S Backos, David J Orlicky, Rebecca L Smathers-McCullough, Dennis R Petersen

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Liver diseases: epidemiology, causes, trends and predictions.Signal transduction and targeted therapy · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Protein Lipoxidation: Basic Concepts and Emerging Roles.Antioxidants (Basel, Switzerland) · 2021
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Transgenic overexpression of CTRP3 prevents alcohol-induced hepatic triglyceride accumulation.American journal of physiology. Endocrinology and metabolism · 2018
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Colin T ShearnFrom the Department of Pharmaceutical Sciences and.
Donald S BackosFrom the Department of Pharmaceutical Sciences and.
David J OrlickyDepartment of Pathology, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado 80045 and.
Rebecca L Smathers-McCulloughDepartment of Pathobiology, Cleveland Clinic, Cleveland, Ohio 44195.
Dennis R PetersenFrom the Department of Pharmaceutical Sciences and Dennis.Petersen@ucdenver.edu.
Pharmaceutical Biotechnology (Czechia) · CZCleveland Clinic · USUniversity of Colorado Anschutz Medical Campus · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Lipid Aldehyde and Ethanol Induced Liver DamageR37AA009300 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI PETERSEN, DENNIS · 2008 to 2017
$4.4M
Lipid Aldehydes and Ethanol Induced Liver DamageR56AA009300 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI PETERSEN, DENNIS · 2007 to 2007
$446k
Regulation of PTEN in chronic alcohol mediated liver diseaseF32AA018613 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI SHEARN, COLIN · 2010 to 2012
$177k
NCATS NIH HHS UL1 TR001082NCI NIH HHS P30 CA046934NCRR NIH HHS UL1 RR025780NIAAA NIH HHS F32 AA018613NIAAA NIH HHS F32 AA018613-03NIAAA NIH HHS R37 AA009300NIAAA NIH HHS R37AA009300-17NIAAA NIH HHS R56 AA009300
6 · The paper itself

Abstract

The production of reactive aldehydes including 4-hydroxy-2-nonenal (4-HNE) is a key component of the pathogenesis in a spectrum of chronic inflammatory hepatic diseases including alcoholic liver disease (ALD). One consequence of ALD is increased oxidative stress and altered β-oxidation in hepatocytes. A major regulator of β-oxidation is 5' AMP protein kinase (AMPK). In an in vitro cellular model, we identified AMPK as a direct target of 4-HNE adduction resulting in inhibition of both H2O2 and 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR)-induced downstream signaling. By employing biotin hydrazide capture, it was confirmed that 4-HNE treatment of cells resulted in carbonylation of AMPKα/β, which was not observed in untreated cells. Using a murine model of alcoholic liver disease, treatment with high concentrations of ethanol resulted in an increase in phosphorylated as well as carbonylated AMPKα. Despite increased AMPK phosphorylation, there was no significant change in phosphorylation of acetyl CoA carboxylase. Mass spectrometry identified Michael addition adducts of 4-HNE on Cys(130), Cys(174), Cys(227), and Cys(304) on recombinant AMPKα and Cys(225) on recombinant AMPKβ. Molecular modeling analysis of identified 4-HNE adducts on AMPKα suggest that inhibition of AMPK occurs by steric hindrance of the active site pocket and by inhibition of hydrogen peroxide induced oxidation. The observed inhibition of AMPK by 4-HNE provides a novel mechanism for altered β-oxidation in ALD, and these data demonstrate for the first time that AMPK is subject to regulation by reactive aldehydes in vivo.

Indexed as

AldehydesAMP-Activated Protein KinasesAnimalsCentral Nervous System DepressantsCysteine Proteinase InhibitorsDisease Models, AnimalEthanolFatty LiverHep G2 CellsHumansLipid PeroxidationLiver Diseases, AlcoholicMaleMiceMice, Inbred C57BLModels, Chemical4-hydroxy-2-nonenalAldehydesAMP-Activated Protein KinasesCentral Nervous System DepressantsCysteine Proteinase InhibitorsEthanolAlcoholAMP-activated Kinase (AMPK)Lipid PeroxidationLiverOxidative Stress

Identifiers

PMID24722988
PMCPMC4140901
OpenAlexW2007825238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.